Chronic MSSA co-infection (n=64) | Chronic Pseudomonas aeruginosa co-infection (n=35) | Chronic Aspergillus co-infection (n=18) | |
---|---|---|---|
During positive MAC sputum culture | 41 (64.1) | 9 (25.7) | 9 (50.0) |
During MAC treatment | 2 (5.4)* | 18 (75.0)* | 9 (81.8)* |
After MAC sputum conversion | 32 (69.6)† | 27 (93.1)† | 9 (81.8)† |
*MAC treatment was received in patients with chronic MSSA co-infection (n=37), chronic P. aeruginosa co-infection (n=24) and chronic Aspergillus co-infection (n=11).
†Patients with chronic MSSA co-infection (n=46), chronic P. aeruginosa co-infection (n=29) and chronic Aspergillus co-infection (n=11) converted sputum culture of MAC.
MAC, Mycobacterium avium complex; MSSA, methicillin-sensitive Staphylococcus aureus.